Measles, mumps and rubella combined vaccine, live attenuated (Shanghai Institute of Biological Products)

麻腮风联合减毒活疫苗（上海生物制品研究所）

Report date: 2024/05/08 17:25:44

Base Information

Drug NameMeasles, mumps and rubella combined vaccine, live attenuated (Shanghai Institute of Biological Products)

Drug Alias NameMeasles/mumps/rubella vaccine (live-attenuated)SIBP MMR Vaccine

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Vaccine type > Combination vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRubellaMumpsMeasles

Global Approved IndicationsRubellaMumpsMeasles

Approved Indications in ChinaRubellaMumpsMeasles

Original Approved Country/TerritoryMainland China

Original Approved Date2007/11/15

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesShanghai Institute of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsRubellaMumpsMeasles

Inactive IndicationsN/A

Other Information

ATC CodeJ07BD52